Holen Sie sich die Stockscreener-App
65.91
0.61%
0.40
Handel nachbörslich:
65.92
0.01
+0.02%
Schlusskurs vom Vortag:
$65.51
Offen:
$65.49
24-Stunden-Volumen:
800.16K
Relative Volume:
0.44
Marktkapitalisierung:
$14.66B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
27.35
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
-2.69%
1M Leistung:
+2.27%
6M Leistung:
+12.02%
1J Leistung:
-19.25%
1-Tages-Spanne:
$65.00
$66.29
1-Wochen-Bereich:
$65.00
$68.98
52-Wochen-Spanne:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
65.91 | 14.57B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.35 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.15 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.26 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth - The Globe and Mail
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now? - Yahoo Finance
Mizuho Adjusts Price Target on Hologic to $70 From $75, Maintains Outperform Rating - MarketScreener
Short interest data insights for Hologic Inc.Dollar Strength & Pattern Based Trade Signal System - newser.com
Using fundamentals and technicals on Hologic Inc.Weekly Loss Report & Real-Time Volume Analysis - newser.com
Will Hologic Inc. rebound enough to break even2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Real time breakdown of Hologic Inc. stock performanceIndex Update & Consistent Growth Equity Picks - newser.com
Statistical indicators supporting Hologic Inc.’s strengthWall Street Watch & Free Community Supported Trade Ideas - newser.com
Best data tools to analyze Hologic Inc. stockJuly 2025 Trends & Low Risk Profit Maximizing Plans - newser.com
Hologic, Inc. (HOLX) Stock Analysis: Exploring Growth Potential Amidst A 7.84% Upside - DirectorsTalk Interviews
Body Fat Measurement Market Poised for Growth, Expected to Hit - openPR.com
What Hologic (HOLX)'s FDA and CE Clearances for GI Assays Mean for Shareholders - Sahm
Hologic Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Hologic (HOLX) Stock Moves -1.25%: What You Should Know - sharewise.com
Hologic (HOLX): Valuation in Focus After Key Regulatory Wins Expand Molecular Diagnostics Portfolio - Sahm
Pattern recognition hints at Hologic Inc. upside2025 Price Action Summary & Long-Term Growth Plans - newser.com
Is Hologic Inc. stock a buy before product launchesJobs Report & Verified Swing Trading Watchlist - newser.com
What the charts say about Hologic Inc. todayJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Infectious Disease Testing Product Market 2025 | Industry - openPR.com
Can Hologic Inc. recover in the next quarterPortfolio Performance Summary & Low Risk Entry Point Guides - newser.com
Is Hologic Inc. stock trading near support levelsRate Cut & Weekly Breakout Watchlists - newser.com
Risk adjusted return profile for Hologic Inc. analyzedDip Buying & Stepwise Trade Signal Implementation - newser.com
Tools to assess Hologic Inc.’s risk profileFed Meeting & Weekly High Return Stock Forecasts - newser.com
Live market analysis of Hologic Inc.Trade Volume Report & Weekly Return Optimization Alerts - newser.com
Is Hologic Set for Growth After FDA Clears New Diagnostic Platform? - Yahoo Finance
Hologic, Inc. Hits Day High with 7.69% Surge in Stock Price - Markets Mojo
What Hologic (HOLX)'s FDA Clearance for GI Assays Means for Shareholders - Yahoo Finance
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation - Yahoo Finance
3 Reasons HOLX is Risky and 1 Stock to Buy Instead - The Globe and Mail
Evercore ISI Group Upgrades Hologic (HOLX) - Nasdaq
Hologic (HOLX) Upgraded to Outperform by Evercore ISI Group | HO - GuruFocus
Hologic (HOLX) Shares Climb After Upgrade by Evercore ISI - GuruFocus
Evercore ISI Upgrades Hologic to Outperform From In Line, Adjusts Price Target to $78 From $69 - MarketScreener
Good practices post-Minerva Surgical, Inc. v. Hologic, Inc. | Latin America | Global law firm - Norton Rose Fulbright
What to do if you’re stuck in Hologic Inc.Earnings Overview Summary & AI Powered Market Entry Ideas - newser.com
How to Play HOLX Stock This Breast Cancer Awareness Month? - The Globe and Mail
How Hologic Inc. (HO1) stock reacts to monetary easingEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Technical analysis overview for Hologic Inc. stock2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Will Dual FDA and CE Approvals for Panther Fusion Shape Hologic's (HOLX) Long-Term Story? - simplywall.st
What dividend safety rating applies to Hologic Inc. (HO1) stockWeekly Trend Summary & Weekly Top Gainers Alerts - newser.com
Should I buy Hologic Inc. (HO1) stock before earnings seasonPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Greenleaf Trust Purchases 173 Shares of Hologic, Inc. $HOLX - Defense World
Chart based analysis of Hologic Inc. trendsTake Profit & Fast Momentum Entry Tips - newser.com
Key metrics from Hologic Inc.’s quarterly dataJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests - MSN
HOLXNew Survey Results Underscore the Need to #BustTheMyth About Mammograms - ADVFN Ltd
Farther Finance Advisors LLC Increases Stock Position in Hologic, Inc. $HOLX - Defense World
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.76%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):